Skip to content

A Trial of Pre-Quitting Nicotine Replacement Therapy

A single blind randomised controlled trial comparing the use of Nicotine Replacement Therapy (NRT) while still smoking for 2 weeks prior to quitting followed by usual NRT practice, with usual NRT cessation practice on smoking abstinence at 6 months.

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12605000373673
Enrollment
1100
Registered
2005-09-13
Start date
2006-03-06
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

The study is a single blind randomised controlled trial of Nicotine replacement therapy (HABITROL: patches and/or gum)while still smoking for two weeks prior to Quit Day followed by usual practice, versus usual practice. Usual practice comprises an 8 week programme of NRT patches and or gum and support calls (eg Quitline) or face to face visits for other cessation providers (eg Aukati Kai Paipa), commencing on Quit Day.

Sponsors

Health Research Council (NZ)
Lead SponsorGovernment body

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Participants will be smokers from throughout New Zealand, who are interested in quitting within the next few days or at most within 2 weeks. Participants will be eligible for inclusion in the trial provided that they are eligible for subsidised NRT according to Quitline criteria. These are as follows: at least 18 years of age, have their first cigarette within 30 minutes of waking (a measure of nicotine dependency)have a telephone, and are able to provide consent.

Exclusion criteria

People will be excluded from the trial if they meet any of the criteria used by Quitline and other cessation providers to decline NRT or to seek medical approval. These are as follows:are pregnant or breastfeedingare current users of NRT productsuse non-cigarette tobacco products (e.g. snuff, pipes, cigars)Is not currently using Zyban (Buproprion) or Nortriptylinehave had a stroke or heart related condition in the last 3 months.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026